(Q45356450)

13 December 2017

title

Clinical characteristics of human immunodeficiency virus-associated Hodgkin lymphoma patients in Japan (English)

1 reference

13 December 2017

1 reference

Nobuyoshi Arima

10

0 references

author name string

Mihoko Yotsumoto

1

1 reference

13 December 2017

Shotaro Hagiwara

2

1 reference

13 December 2017

Atsushi Ajisawa

3

1 reference

13 December 2017

Junko Tanuma

4

1 reference

13 December 2017

Tomoko Uehira

5

1 reference

13 December 2017

Hirokazu Nagai

6

1 reference

13 December 2017

Yuko Fujikawa

7

1 reference

13 December 2017

Shunichi Maeda

8

1 reference

13 December 2017

Kiyoshi Kitano

9

1 reference

13 December 2017

Kenji Uno

11

1 reference

13 December 2017

Toshiki Iwai

12

1 reference

13 December 2017

Igen Hongo

13

1 reference

13 December 2017

Yasunori Ota

14

1 reference

13 December 2017

Katsuyuki Fukutake

15

1 reference

13 December 2017

Seiji Okada

16

1 reference

13 December 2017

publication date

1 July 2012

1 reference

International Journal of Hematology

13 December 2017

published in

1 reference

13 December 2017

volume

96

1 reference

13 December 2017

issue

2

1 reference

13 December 2017

page(s)

247-253

1 reference

13 December 2017

cites work

Update on HIV lymphoma

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1127-5

Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1127-5

Trends in cancer risk among people with AIDS in the United States 1980-2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1127-5

Characteristics of non-AIDS-defining malignancies in the HAART era: a clinico-epidemiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1127-5

Cancer burden in the HIV-infected population in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1127-5

Strong impact of highly active antiretroviral therapy on survival in patients with human immunodeficiency virus-associated Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1127-5

Non-AIDS-Defining Malignancies in Patients with HIV in the HAART Era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1127-5

Hodgkin's Disease in Patients with HIV Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1127-5

Results of treatment with doxorubicin, bleomycin, vinblastine and dacarbazine and highly active antiretroviral therapy in advanced stage, human immunodeficiency virus-related Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1127-5

Stanford V regimen and concomitant HAART in 59 patients with Hodgkin disease and HIV infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1127-5

Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1127-5

A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1127-5

Cancer risk among men with, or at risk of, HIV infection in southern Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1127-5

HIV-associated Hodgkin lymphoma during the first months on combination antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1127-5

Pathogenetic and histogenetic features of HIV-associated Hodgkin's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1127-5

Phase II study of ABVd therapy for newly diagnosed clinical stage II-IV Hodgkin lymphoma: Japan Clinical Oncology Group study (JCOG 9305).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1127-5

Prognostic analysis and a new risk model for Hodgkin lymphoma in Japan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1127-5

Immunodeficiency-related Hodgkin lymphoma and its mimics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1127-5

HIV-associated Hodgkin lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1127-5

Epstein-Barr virus in the pathogenesis of Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1127-5

Hodgkin's disease and the Epstein-Barr virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1127-5

Decrease in Epstein-Barr virus-positive AIDS-related lymphoma in the era of highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1127-5

Hodgkin's disease during HIV1 infection: the French registry experience. French Registry of HIV-associated Tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1127-5

Hodgkin's disease associated with human immunodeficiency virus infection. A clinical study of 46 cases. Cooperative Study Group of Malignancies Associated with HIV Infection of Madrid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1127-5

Systemic chemotherapy for HIV-associated lymphoma in the era of highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1127-5

Epstein-Barr virus as a marker of survival after Hodgkin's lymphoma: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1127-5

Stanford V and radiotherapy for locally extensive and advanced Hodgkin's disease: mature results of a prospective clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1127-5

High international prognostic score predicts a worse outcome for patients with Hodgkin's disease and HIV infection: results of a prospective study with Stanford V regimen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1127-5

Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1127-5

High-dose therapy and autologous peripheral blood stem cell transplantation as salvage treatment for AIDS-related lymphoma: long-term results of the Italian Cooperative Group on AIDS and Tumors (GICAT) study with analysis of prognostic factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1127-5

Dose-reduced busulfan, cyclophosphamide, and autologous stem cell transplantation for human immunodeficiency virus-associated lymphoma: AIDS Malignancy Consortium study 020.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1127-5

Incidence of AIDS-Defining Cancers After AIDS Diagnosis Among People with AIDS in Italy, 1986–1998

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1127-5

Chemotherapy consisting of doxorubicin, bleomycin, vinblastine, and dacarbazine with granulocyte-colony-stimulating factor in HIV-infected patients with newly diagnosed Hodgkin's disease: a prospective, multi-institutional AIDS clinical trials group

21 January 2018

1 reference

12 December 2020

Actual status of AIDS-related lymphoma management in Japan

1 reference

12 December 2020

The world health organization classification of malignant lymphomas in japan: incidence of recently recognized entities. Lymphoma Study Group of Japanese Pathologists

1 reference

12 December 2020

Human immunodeficiency virus-associated Hodgkin's disease derives from post-germinal center B cells

1 reference

12 December 2020

10.1007/S12185-012-1127-5

Identifiers

DOI

1 reference

Dimensions Publication ID

13 December 2017

1051212533

0 references

1 reference